Skip to content
Home/Companies/Biotech/Roslinct
RO

Roslinct

Biotech·UK·Active·5yr hold

Roslinct is a healthcare company, headquartered in United Kingdom.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Roslinct?

Roslinct is currently owned by GHO Capital through GHO Capital III LP (2021 vintage), since 2021.

Hand-verified · updated 2026-04-21

GHO Capital
Investor
GHO Capital
GHO Capital III LP · 2021 · Buyout

Key facts

HQUnited Kingdom
SectorHealthcare

More from GHO Capital III LP

Other portfolio companies in the same fund.

Alcami Corporation
Active
PharmaUnited States· 2022
Sanner
Active
MedTechGermany· 2022
Sapio Sciences
Active
HealthTechUnited States· 2022
Biocare Medical
Exited 2026
MedTechUnited States· 2021
to
Clearview Healthcare Partners
Active
Business ServicesUnited States· 2021
Genesis Research
Active
HealthTechUnited States· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings